Article
Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma.
Cell death & disease - 15 Jan 2015
Singer E, Judkins J, Salomonis N, Matlaf L, Soteropoulos P, McAllister S, Soroceanu L
Abstract excerpt
Glioblastoma (GBM) resistance to therapy is the most common cause of tumor recurrence, which is ultimately fatal in 90% of the patients 5 years after initial diagnosis. A sub-population of tumor cells with stem-like properties, glioma stem cells (GSCs), is specifically endowed to resist or adapt to the standard therapies, leading to therapeutic resistance. Several anticancer agents, collectively termed redox...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
